Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement Post author:GHIAA Admin Post published:September 28, 2022 Post category: Continue ReadingGilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement
Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement Post author:GHIAA Admin Post published:September 27, 2022 Post category: Continue ReadingGilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement
Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement Post author:GHIAA Admin Post published:July 25, 2022 Post category: Continue ReadingSanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
University of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement Post author:GHIAA Admin Post published:January 11, 2022 Post category: Continue ReadingUniversity of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement
University of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement Post author:GHIAA Admin Post published:January 8, 2022 Post category: Continue ReadingUniversity of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement
Merck – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 19, 2021 Post category: Continue ReadingMerck – MPP, Molnupiravir License Agreement
Moderna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement Post author:GHIAA Admin Post published:November 19, 2021 Post category: Continue ReadingModerna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement
Moderna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement Post author:GHIAA Admin Post published:November 18, 2021 Post category: Continue ReadingModerna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement
Moderna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement Post author:GHIAA Admin Post published:November 18, 2021 Post category: Continue ReadingModerna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement